30 results
DEF 14A
NTBL
Notable Labs Ltd
16 Feb 24
Definitive proxy
9:00am
for chair
Nominating and Corporate Governance Committee:
Members (other than chair)
Retainer for chair
In addition, the non-employee director compensation … Committee:
Members (other than chair)
Retainer for chair
Compensation Committee:
Members (other than chair)
Retainer for chair
Nominating and Corporate
PRE 14A
NTBL
Notable Labs Ltd
5 Feb 24
Preliminary proxy
5:00pm
than chair)
Retainer for chair
Nominating and Corporate Governance Committee:
Members (other than chair)
Retainer for chair
In addition, the non …
Nominating and Corporate Governance Committee:
Members (other than chair)
Retainer for chair
In special circumstances, such as in the case
8-K
NTBL
Notable Labs Ltd
16 Oct 23
Notable Labs Closes Merger Transaction With VBL Therapeutics
4:05pm
will operate pursuant to and apply the Company’s written charters and corporate governance policies currently in place. Thereafter, the Company’s board
424B3
s7m9mjul4s31cg4
5 Sep 23
Prospectus supplement
6:02pm
S-4/A
asxpl 0rwp260
30 Jun 23
Registration of securities issued in business combination transactions (amended)
4:38pm
S-4
ijpelga gu
11 May 23
Registration of securities issued in business combination transactions
9:09am
S-4
EX-10.9
gqi37o rh0y
11 May 23
Registration of securities issued in business combination transactions
9:09am
6-K
EX-99.3
0yr190cq0t5vk9wt 4d
14 Nov 22
VBL Therapeutics Reports Third Quarter 2022 Financial Results
4:19pm
6-K
EX-99.3
pmoj u3hc6fq15
15 Aug 22
VBL Therapeutics Announces Second Quarter 2022 Financial Results
4:07pm
6-K
EX-99.2
amnako 082cae1tfa9k4
2 Jun 22
Notice of Annual General Meeting of Shareholders
5:00pm
6-K
EX-99.3
4m6hrkxa218r6oeq 7lh
17 May 22
VBL Therapeutics Reports First Quarter 2022 Financial Results
7:00am
6-K
b8d58rbmx3j o3i
20 Oct 21
Current report (foreign)
4:01pm
6-K
EX-99.1
n4c3i57q24
2 Sep 21
Notice of Annual General Meeting of Shareholders
7:20am
6-K
EX-99.2
ij0yfw9
2 Sep 21
Notice of Annual General Meeting of Shareholders
7:20am